Abstract
In 2015, several provinces in Lao People's Democratic Republic (Lao PDR) experienced a vaccine-derived poliovirus outbreak. This survey was conducted (i) to evaluate the vaccination coverage in different settings and cohorts using the seroprevalence of anti-poliovirus (PV) antibodies as a surrogate measure, and (ii) to explore the usefulness of an ELISA in a country with limited resources and a specific epidemiological setting. IgG antibodies were assessed by ELISA in Lao children (n = 1216) and adults (n = 1228), including blood donors and health care workers. Protective antibody titers against the 3 vaccine serotypes were determined by microneutralization (VNT) in a subset of participants. More than 92% of the children had anti-poliovirus antibodies, regardless of nutritional status or access to health care, highlighting the success of the vaccination outreach activities in the country. In contrast, anti-poliovirus seroprevalence reached only 81.7% in blood donors and 71.9% in health care workers. Participants born before the introduction of poliovirus vaccination in Lao PDR were considerably less likely to be seropositive. These findings align with the epidemiology of the outbreak. Neutralizing antibodies against at least one of the 3 poliovirus serotypes were detected in all children (99/99) and 93/99 had antibodies against all serotypes. Similarly, all health care workers had neutralizing antibodies against at least one and 92/99 against all serotypes. The comparison of both assays shows an acceptable underestimation of vaccine coverage in children by ELISA, but a low sensitivity of the ELISA in the adults. We show that the ELISA is a reasonable alternative to the VNT in particular in vaccinated children, that an improved version should be serotype specific, and that negativity thresholds should be revisited for optimal sensitivity and specificity. Thus, polio-free countries with an uncertain vaccination coverage and limited laboratory capacity, that are at risk of vaccine-derived poliovirus outbreaks or of re-importation of wild poliovirus may benefit from an improved ELISA for cohort studies to evaluate their immunization program in children.
Highlights
Large-scale vaccination campaigns eliminated wild poliovirus (WPV) in most countries of the world and WPV remains endemic only in Pakistan, Nigeria and Afghanistan [1]
In the Lao People’s Democratic Republic (Lao PDR), oral polio vaccine (OPV) was introduced in the early eighties, and vaccination was expanded to the whole country in the nineties [2]
In 1996, the last case of WPV was reported in Lao PDR and in 2000, the Western Pacific Region, including Lao PDR, was certified polio-free [3, 4]
Summary
Large-scale vaccination campaigns eliminated wild poliovirus (WPV) in most countries of the world and WPV remains endemic only in Pakistan, Nigeria and Afghanistan [1]. In the Lao People’s Democratic Republic (Lao PDR), oral polio vaccine (OPV) was introduced in the early eighties, and vaccination was expanded to the whole country in the nineties [2]. Despite its ground-breaking role in the eradication of poliovirus (PV), OPV (containing live attenuated PV strains) has some important drawbacks. In countries with suboptimal vaccination coverage levels and weak acute flaccid paralysis (AFP) surveillance, excreted vaccine-virus can replicate and circulate for a prolonged time. Within less than a year of circulation, vaccine viruses may accumulate genetic mutations and neurovirulent vaccinederived PV (VDPV) may emerge [6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.